Attenuation of extracellular ATP response in cardiomyocytes isolated from hearts subjected to ischemia-reperfusion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Saini, Harjot K ^b   Elimban, Vijayan ^b   Dhalla, Naranjan S ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

Ischemic preconditioning; Isolated cardiomyocytes; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CALCIUM ION; CIBACRON BLUE F3GA; FURA 2; HYDROGEN PEROXIDE; SULFUR 35; VERAPAMIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INOTROPISM; ISOLATED HEART; MALE; MICROFLUOROMETRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SIMULATION;

ADENOSINE TRIPHOSPHATE; ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM; CATALASE; CELL HYPOXIA; CELL SEPARATION; EXTRACELLULAR FLUID; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; INTRACELLULAR MEMBRANES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOPROTERENOL; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; OSMOLAR CONCENTRATION; OXIDANTS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 23744455583     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00101.2005     Document Type: Article

References (46)

1. 2+ responses in intact hearts. Am J Physiol Heart Circ Physiol 281: H1508-H1523, 2001.
2. Asemu G, Tappia PS, and Dhalla NS. Identification of the changes in phospholipase C isozymes in ischemic-reperfused rat heart. Arch Biochem Biophys 411: 174-182, 2003.
3. Bers DM. Ryanodine and calcium content of cardiac SR assessed by caffeine and rapid cooling contractures. Am J Physiol Cell Physiol 253: C408-C415, 1987.
4. Buerke M, Rupprecht HJ, vom Dahl J, Terres W, Seyfarth M, Schultheiss HP, Richardt G, Sheehan FH, and Drexler H. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion. Am J Cardiol 83: 19G-22G, 1999.
5. Burnstock G and Kennedy C. A dual function for adenosine 5′-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res 58: 319-330, 1986.
6. Burnstock G. Noradrenaline and ATP: cotransmitters and neuromodulators. J Physiol Pharmacol 46: 365-384, 1995.
7. Carvajal K and Moreno-Sanchez R. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res 34: 89-99, 2003.
8. Chandrashekhar Y, Prahash AJ, Sen S, Gupta S, and Anand IS. Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities. J Am Coll Cardiol 34: 594-602, 1999.
9. 2+ concentration in isolated rat ventricular myocytes. J Physiol 445: 369-388, 1992.
10. 2+. Am J Physiol Cell Physiol 257: C750-C758, 1989.
11. Dhalla NS, Elmoselhi AB, Hata T, and Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47: 446-456, 2000.
12. +-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol Cell Physiol 262: C664-C671, 1992.
13. Downey JM, Omar B, Ooiwa H, and McCord J. Superoxide dismutase therapy for myocardial ischemia. Free Radic Res Commun 12-13: 703-720, 1991.
14. 2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 76: 1036-1048, 1995.
15. Gu XH, Dillon JS, and Nayler WG. Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time. J Cardiovasc Pharmacol 12: 272-278, 1988.
16. 2+ handling. Circ Res 89: 831-837, 2001.
17. 2 receptor subtypes in the cardiovascular system. Biochem J 336: 513-523, 1998.
18. Kuzmin AI, Lakomkin VL, Kapelko VI, and Vassort G. Interstitial ATP level and degradation in control and postmyocardial infarcted rats. Am J Physiol Cell Physiol 275: C766-C771, 1998.
19. i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ Res 66: 1255-1267, 1990.
20. Meij JT, Suzuki S, Panagia V, and Dhalla NS. Oxidative stress modifies the activity of cardiac sarcolemmal phospholipase C. Biochim Biophys Acta 1199: 6-12, 1994.
21. 2+ modulation during postischemic reperfusion in rat heart. Am J Physiol Heart Circ Physiol 268: H100-H111, 1995.
22. Musat S and Dhalla NS. Alteration in cardiac sarcolemmal ATP receptors by oxyradicals. Ann NY Acad Sci 793: 1-12, 1996.
23. Nayler WG. Basic mechanisms involved in the protection of the ischaemic myocardium. The role of calcium antagonists. Drugs 42, Suppl 2: 21-27, 1991.
24. Neely JR and Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res 55: 816-824, 1984.
25. Nelson SK, Gao B, Bose S, Rizeq M, and McCord JM. A novel heparin-binding, human chimeric, superoxide dismutase improves myocardial preservation and protects from ischemia-reperfusion injury. J Heart Lung Transplant 21: 1296-1303, 2002.
26. Persad S, Takeda S, Panagia V, and Dhalla NS. β-Adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals. J Mol Cell Cardiol 29: 545-558, 1997.
27. 3 generation. Biochem J 318: 723-728, 1996.
28. +-induced increase in intracellular calcium in KCl-depolarized rat cardiomyocytes. Mol Cell Biochem 263: 151-162, 2004.
29. 2+ release channel. Am J Physiol Cell Physiol 253: C364-C368, 1987.
30. Saini HK and Dhalla NS. Defective calcium handling in cardiomyocytes isolated from hearts subjected to ischemia-reperfusion. Am J Physiol Heart Circ Physiol 288: H2260-H2270, 2005.
31. Saini HK, Shao Q, Musat S, Takeda N, Tappia PS, and Dhalla NS. Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction. Br J Pharmacol 144: 202-211, 2005.
32. Scamps F, Legssyer A, Mayoux E, and Vassort G. The mechanism of positive inotropy induced by adenosine triphosphate in rat heart. Circ Res 67: 1007-1016, 1990.
33. Shattock MJ. Myocardial stunning: do we know the mechanism? Basic Res Cardiol 92, Suppl 2: 18-22, 1997.
34. Stamm C, Friehs I, Cowan DB, Cao-Danh H, Noria S, Munakata M, McGowan FX Jr, and del Nido PJ. Post-ischemic PKC inhibition impairs myocardial calcium handling and increases contractile protein calcium sensitivity. Cardiovasc Res 51: 108-121, 2001.
35. 2+ exchange. Circ Res 65: 1045-1056, 1989.
36. Temsah RM, Kawabata K, Chapman D, and Dhalla NS. Preconditioning prevents alterations in cardiac SR gene expression due to ischemia-reperfusion. Am J Physiol Heart Circ Physiol 282: H1461-H1466, 2002.
37. Vassort G. Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81: 767-806, 2001.
38. Wang QD, Swardh A, and Sjoquist PO. Relationship between ischemic time and ischemia/reperfusion injury in isolated Langendorff-perfused mouse hearts. Acta Physiol Scand 171: 123-128, 2001.
39. Wang X, Dakshinamurti K, Musat S, and Dhalla NS. Pyridoxal 5′-phosphate is an ATP-receptor antagonist in freshly isolated rat cardiomyocytes. J Mol Cell Cardiol 31: 1063-1072, 1999.
40. Wang X, Takeda S, Mochizuki S, Jindal R, and Dhalla NS. Mechanisms of hydrogen peroxide-induced increase in intracellular calcium in cardiomyocytes. J Cardiovasc Pharmacol Ther 4: 41-48, 1999.
41. 2+ to phosphatidic acid in chronic diabetes. Can J Cardiol 12: 1092-1098, 1996.
42. Zheng JS, Christie A, De Young MB, Levy MN, and Scarpa A. Synergism between cAMP and ATP in signal transduction in cardiac myocytes. Am J Physiol Cell Physiol 262: C128-C135, 1992.
43. 2+ mobilization by extracellular ATP in rat cardiac myocytes: regulation by protein kinase C and A. Am J Physiol Cell Physiol 263: C933-C940, 1992.
44. Zucchi R, Ronca F, and Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol Ther 89: 47-65, 2001.
45. Zucchi R, Ronca-Testoni S, Yu G, Galbani P, Ronca G, and Mariani M. Are dihydropyridine receptors downregulated in the ischemic myocardium? Cardiovasc Res 30: 769-774, 1995.
46. 2+ channels. Circ Res 74: 271-280, 1994.